ArticleCureus2025
Early Intervention Referral Rates of Infants With Neonatal Opioid Withdrawal Syndrome Are Not Significantly Affected by Race, Payor, Maternal Medication for Opioid Use Disorder, or NICU Hospitalization.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pharmacogenetic exploration of buprenorphine and related metabolites in umbilical cord blood.Toxicology reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, we examined the factors influencing enrollment in early intervention (EI) programs for neonates diagnosed with nonopioid-associated neonatal abstinence syndrome (NAS) and neonatal opioid withdrawal syndrome (NOWS). The primary goal was to examine characteristics linked to completing an individualized family service plan (IFSP), marking EI enrollment. Patient records were reviewed using data from neonates discharged with NOWS/NAS at a Massachusetts hospital in 2017 to identify demographic and medical factors related to NOWS/NAS cases. Out of 125 cases, 111 were analyzed, with patient outcomes analyzed in subgroups of those with NOWS and non-opioid-associated NAS. Findings indicated that neonates with NICU hospitalization, race, payor, and maternal medication for opioid use disorder (MOUD) did not have significantly different rates of IFSP completion. Additionally, no significant difference was observed in IFSP completion rates between neonates with NAS or NOWS. This study reports baseline data from a quality improvement initiative not designed to detect statistically significant differences. However, it highlights potential areas for further investigation to improve EI access for NOWS- and NAS-affected neonates, although more extensive studies are needed to further elucidate these differences.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.